{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:31:04Z","timestamp":1791412264291,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T00:00:00Z","timestamp":1412985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.neo.2014.09.011","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T21:49:13Z","timestamp":1418075353000},"page":"1059-1069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The Transcriptional Repressor ZBTB4 Regulates EZH2 Through a MicroRNA-ZBTB4-Specificity Protein Signaling Axis"],"prefix":"10.1016","volume":"16","author":[{"given":"Won Seok","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Chadalapaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Gook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syng-ook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Un-Ho","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Jutooru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangmin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuet-Kin","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuk-Mei","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Safe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyounghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2014.09.011_bb0005","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1158\/0008-5472.CAN-06-3735","article-title":"Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors","volume":"67","author":"Chintharlapalli","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2407-11-371","article-title":"Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors","volume":"11","author":"Chintharlapalli","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2014.09.011_bb0015","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/ijc.24530","article-title":"Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells","volume":"125","author":"Chintharlapalli","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2014.09.011_bb0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.110.064451","article-title":"Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a","volume":"78","author":"Jutooru","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neo.2014.09.011_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/1541-7786.MCR-09-0493","article-title":"Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells","volume":"8","author":"Chadalapaka","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0030","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1158\/0008-5472.CAN-07-6805","article-title":"Curcumin decreases specificity protein expression in bladder cancer cells","volume":"68","author":"Chadalapaka","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnci\/djj232","article-title":"Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation","volume":"98","author":"Abdelrahim","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.neo.2014.09.011_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1158\/1541-7786.MCR-10-0363","article-title":"GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species - microRNA-27a: ZBTB10-specificity protein pathway","volume":"9","author":"Pathi","year":"2011","journal-title":"Mol Cancer Res"},{"issue":"13","key":"10.1016\/j.neo.2014.09.011_bb0045","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/MCB.01602-13","article-title":"Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents","volume":"34","author":"Jutooru","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neo.2014.09.011_bb0050","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-07-2416","article-title":"The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells","volume":"67","author":"Mertens-Talcott","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0055","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/onc.2011.296","article-title":"Identification of oncogenic microRNA-17-92\/ZBTB4\/specificity protein axis in breast cancer","volume":"31","author":"Kim","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2014.09.011_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201100187","article-title":"Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer","volume":"4","author":"Park","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.neo.2014.09.011_bb0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-010-0897-9","article-title":"A gene expression signature identifies two prognostic subgroups of basal breast cancer","volume":"126","author":"Sabatier","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.neo.2014.09.011_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/bioinformatics\/btm541","article-title":"Gene set expression comparison kit for BRB-array tools","volume":"24","author":"Xu","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2014.09.011_bb0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neo.2014.09.011_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/nar\/28.1.316","article-title":"TRANSFAC: an Integrated system for gene expression regulation","volume":"28","author":"Wingender","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0085","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1158\/0008-5472.CAN-06-3494","article-title":"Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A","volume":"67","author":"Jia","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/me.2004-0326","article-title":"Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer","volume":"19","author":"Kim","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.neo.2014.09.011_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2008.04.001","article-title":"miRiad roles for the miR-17\u201392 cluster in development and disease","volume":"133","author":"Mendell","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neo.2014.09.011_bb0100","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/gb-2007-8-10-r214","article-title":"MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype","volume":"8","author":"Blenkiron","year":"2007","journal-title":"Genome Biol"},{"issue":"14","key":"10.1016\/j.neo.2014.09.011_bb0105","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","article-title":"Cell Miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set","volume":"72","author":"Reinhold","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0110","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-11-0608","article-title":"MicroRNA sequence and expression analysis in breast tumors by deep sequencing","volume":"71","author":"Farazi","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0115","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nrc1991","article-title":"Polycomb silencers control cell fate, development and cancer","volume":"6","author":"Sparmann","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2014.09.011_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng1531","article-title":"Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer","volume":"37","author":"Fraga","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.neo.2014.09.011_bb0125","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neo.2014.09.011_bb0130","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1035902","article-title":"Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein","volume":"16","author":"Kuzmichev","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.neo.2014.09.011_bb0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/35020506","article-title":"Regulation of chromatinstructure by site-specific histone H3 methyltransferases","volume":"406","author":"Rea","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neo.2014.09.011_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Simon","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0145","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1078-0432.CCR-05-1533","article-title":"Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer","volume":"12","author":"Collett","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0150","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","article-title":"EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast","volume":"24","author":"Bachmann","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2014.09.011_bb0155","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2014.09.011_bb0160","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1158\/0008-5472.CAN-05-4300","article-title":"Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues","volume":"66","author":"Ding","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1476-5586(03)80032-5","article-title":"Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene","volume":"5","author":"Raaphorst","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2014.09.011_bb0170","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.neo.2014.09.011_bb0175","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.neo.2014.09.011_bb0180","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/onc.2008.433","article-title":"Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1","volume":"28","author":"Gonzalez","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2014.09.011_bb0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccr.2010.10.035","article-title":"EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling","volume":"19","author":"Chang","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2014.09.011_bb0190","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/sj.onc.1207706","article-title":"Activated p53 suppresses the histone methyltransferase EZH2 gene","volume":"23","author":"Tang","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2014.09.011_bb0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/gad.864201","article-title":"E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis","volume":"15","author":"Muller","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.neo.2014.09.011_bb0205","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1074\/jbc.M709614200","article-title":"MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis","volume":"283","author":"Wong","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neo.2014.09.011_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgq209","article-title":"Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer","volume":"32","author":"Zhang","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neo.2014.09.011_bb0215","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Varambally","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neo.2014.09.011_bb0220","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/0008-5472.CAN-08-3114","article-title":"The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2","volume":"69","author":"Friedman","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.09.011_bb0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2010.03.051","article-title":"Curcumin induces down- regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells","volume":"637","author":"Hua","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neo.2014.09.011_bb0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mc.21893","article-title":"Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of Sp transcription factors and microRNA-27a:ZBTB10","volume":"52","author":"Mertens-Talcott","year":"2013","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.neo.2014.09.011_bb0235","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1158\/1535-7163.MCT-12-0026","article-title":"Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of MicroRNA-27a:ZBTB10 in breast cancer","volume":"11","author":"Liu","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neo.2014.09.011_bb0240","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: oncogene and non-oncogene addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neo.2014.09.011_bb0245","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1158\/0008-5472.CAN-10-0027","article-title":"Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558614001468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558614001468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:04:29Z","timestamp":1761483869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558614001468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1476558614001468"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2014.09.011","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Transcriptional Repressor ZBTB4 Regulates EZH2 Through a MicroRNA-ZBTB4-Specificity Protein Signaling Axis","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2014.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}